High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

Sebastiaan Somers; Patty M. Jansen; Hendrik Veelken; Maarten H. Vermeer; Willem Kraan; Anne-Roos Schrader; Ward Posthuma; Marcel Nijland; Arjan Diepstra; Marie José Kersten

doi:10.1182/blood.v130.suppl_1.4000.4000

High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

NobleID: NI8P98W50R11S60
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/D3AEF4F0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D3AEF4F0.svg?ark=w1%2F20260515%2FD3AEF4F0&value=id)](https://nobleid.org/work/w1/20260515/D3AEF4F0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

NobleID: NI8P98W50R11S60
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/D3AEF4F0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D3AEF4F0.svg?ark=w1%2F20260515%2FD3AEF4F0&value=id)](https://nobleid.org/work/w1/20260515/D3AEF4F0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work